Manute Bol, a Sudanese-American professional basketball player and political activist, died from acute kidney failure and complications from Stevens-Johnson syndrome (SJS) in 2010 at the age of 47.
A UK study found persistent non-attendance of ophthalmic telemedicine appointments was associated with underserved populations. Moorfields Eye Hospital researchers conducted an evaluation of 85,924
The annual International Agency for the Prevention of Blindness (IAPB) World Sight Day photo competition is open for submissions and includes a new category, ‘Love Your Eyes at Work’.
A US study found an immersive continuing education (CE) initiative resulted in significant knowledge and competence gains among retinal disease care providers and changes in practice-related treatment behaviours.
The world’s first synthetic and non-degradable ophthalmic tissue-integrating substitute, EverPatch, should be available in the US by the end of 2023, said its manufacturer CorNeat Vision.
Eyerising International’s at-home device for myopia control is now listed by the Australian Therapeutic Goods Administration (TGA). Already approved for sale in Europe, the Eyerising Myopia
Myopia Profile, the international clinical myopia management information centre for eyecare professionals (ECPs), has announced several developments for September’s inaugural Myopia Action Month. The
In 2022, Maddy Scavone, Melbourne paediatric orthoptist and founder of amblyopic patches company Speckles, told NZ Optics, “Really, a lot of kids’ sunglasses are toys unless they have good UV
Contact lens educators from Colombia, India and Jordan received this year’s prestigious awards from the International Association of Contact Lens Educators (IACLE) for their outstanding contributions
Phase 2b trials of Orasis Pharmaceuticals’ presbyopia treatment, CSF-1 (0.4% pilocarpine HCl) showed 80% patients achieved a two-line improvement in near vision, comparable to achieving 20/40 or
Aiming to establish a trans-Tasman network to collaboratively devise new strategies to benefit patients and the eye health sector, Specsavers held its first cross-sector meeting for patient support bodies from Australia and New Zealand.
Hoya Vision Care has launched a Miyosmart sun range of photochromic or polarised lenses to provide sun protection while slowing myopia progression in children. Miyosmart Chameleon (photochromic) and
